Tom Brady's eMed health startup valued at $2 billion

Digital healthcare startup eMed has achieved a valuation exceeding $2 billion following a $200 million Series A funding round. The company, which focuses on GLP-1 treatments, secured this significant investment from a group including AON Consulting and retired NFL star Tom Brady. Brady, who recently took on the role of chief wellness officer, is a key figure in the company's strategic direction. This funding round underscores strong investor confidence in eMed's business model and its potential within the rapidly growing digital health and wellness sector, particularly in specialized treatment areas.